Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Valeant Offers to Buy Botox Maker Allergan With Pershing Support

Allergan Inc.’s Botox wrinkle treatment is arranged at a hospital in Boston. Photographer: JB Reed/Bloomberg
Allergan Inc.’s Botox wrinkle treatment is arranged at a hospital in Boston. Photographer: JB Reed/Bloomberg

Valeant Pharmaceuticals International Inc. offered to buy Allergan Inc. for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment.

Allergan investors would receive $48.30 in cash and 0.83 percent of a Valeant share in the deal, Valeant said in a statement today. Pershing Square Management LP, Allergan’s largest shareholder with 9.7 percent of shares outstanding, supports the purchase, Valeant said. The per-share value of the offer is based on yesterday’s closing price.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.